About QID Pharma
QID Pharma is a company based in Surrey Hills (Australia) founded in 2017. QID Pharma operates in a competitive market with competitors including Amryt Pharma, Castle Creek Biosciences, Eicos Sciences and LifeMax, among others.
- Headquarter Surrey Hills, Australia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of QID Pharma
Detailed funding history for QID Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by QID Pharma
Investment portfolio details for QID Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - QID Pharma
Detailed financials for QID Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qid Pharma Comparisons
Peer comparison for QID Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of QID Pharma
QID Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amryt Pharma, Castle Creek Biosciences, Eicos Sciences and LifeMax, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for rare dermatological and orphan diseases are developed.
|
|
| Locked | Locked | Locked |
Gene therapy platform for rare disease treatments is developed.
|
|
| Locked | Locked | Locked |
Develops Prostacyclin-based therapies for underserved medical conditions globally.
|
|
| Locked | Locked | Locked |
Develops innovative therapeutic solutions for Netherton syndrome treatment.
|
Detailed competitors of QID Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qid Pharma
Complete news archive for QID Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QID Pharma
QID Pharma was founded in 2017.
QID Pharma is headquartered in Surrey Hills, Australia. It is registered at Surrey Hills, Victoria, Australia.
QID Pharma was founded in 2017 in Surrey Hills, Australia, within the biotechnology sector. Therapeutics are developed by the company for rare diseases, targeting a severe genetic dermatology disorder that impacts infants, children, and adults. Operations center on advancing treatments for this condition, with ongoing product development conducted from the Australian base to address unmet medical needs in rare disease care.
QID Pharma's top competitors include Castle Creek Biosciences, Amryt Pharma and Eicos Sciences.